Encore Tablets recalled by FDA, Bodee LLC

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The therapy is now the first and only oral on-demand treatment option for the condition.

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.